Delivery Order SPE2DB24D8003-SPE2DB25FJUBX

Award Date 3/27/25
Potential Completion Date 3/28/25
Potential Value $6.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,027.24 firm fixed price contract is for the delivery of 4,563,197,924 units of Methylphenidate ER 27 mg tablets in 100 count packages. This contract has an ultimate completion date of December 29, 2023. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of 4,567,223,219 units of Methylphenidate ER 54 mg tablets in 100-count bottles. The contract has a firm fixed price of $3,300.05 and a period of performance through February 11, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc., identified as SPE2DB24D8001,...
This federal contract award is for the delivery of Methylphenidate ER 36 mg tablets in 100-count packages to the Defense Logistics Agency (DLA). The $3,362.34 firm fixed-price delivery order was awarded to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The award is not set-aside and has an ultimate completion date of May 28, 2025. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $3,648.51 fixed-price contract is for the delivery of 100 count bottles of the medication Methylphenidate ER 36 mg tablets. The contract has a completion date of May 22, 2025. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA's Troop Support Medical ECAT...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $4,178.40 firm fixed-price delivery order, identified as SPE2DB24FKYZG, is for the supply of 4,565,632,881 units of Methylphenidate ER 27 mg tablets in 100-count bottles. This order is part of a larger Indefinite Delivery Contract (IDC), SPE2DB24D8001,...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4566327375 - Methylphenidate ER 36 MG Tablets in 100 count bottles. The contract has a ceiling value of $1,664.43 and a period of performance through November 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC), SPE2DB24D8001, held by Dakota Drug, Inc. under the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of 100 bottles of 30mg extended-release methylphenidate tablets to support military medical operations. The contract has a total ceiling value of $1,424.57 and a period of performance through October 16, 2023. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the delivery of Methylphenidate ER 27 mg tablets in quantities of 100. The contract has a firm fixed price of $3,937.10 and a period of performance through May 19, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) that Dakota Drug, Inc. holds with the DLA, identified as...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,172.38 firm fixed price delivery order is for the supply of CONCERTA ER 36 MG TABLET 100S. The contract has a performance period through November 19, 2024 and is not designated as a set-aside. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA under the ECAT Generation V Program, which allows the company to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $7,937.66 firm fixed-price contract is for the supply of 4,564,042,715 units of the pharmaceutical product Methylphenidate ER 27 mg tablets with an ultimate completion date of March 22, 2024. No set-aside was used for this award. Dakota Drug, Inc. has over two decades of experience as a prime contractor to the federal government,...
  • SPE2DB24D8003
    Indefinite Delivery Contract
  • SPE2DB24D8003-SPE2DB25FJUBX
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4,567,720,329 units of Methylphenidate ER 27 mg tablets in 100-count bottles. The $6,259.23 contract has a performance period ending on March 28, 2025.

Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the agency's ECAT Generation V Program, which allows the company to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. This particular delivery order is not associated with a set-aside program.

Generated 6/26/25, 10:12 AM